Rare diseases are rapidly becoming a high priority therapeutic area for our industry. This is needed, especially when fewer than 5% of approx 7,000 rare diseases have drug therapies available, and many of these provide limited benefit. There is also a business case to this, due to a supportive reimbursement environment, particularly in the US. […]

Read More →

Cost and time for clinical development constitute more than 70% of total development of any drug! Small – mid scale biopharma are known for their innovative approaches, agility and faster developments. However, clinical development has always been one step too important, yet too hard for them. There are ways to overcome these challenges and optimize […]

Read More →

Rare disease drug development is a rapidly expanding field with growing pressure for getting more orphan drug approved to treat rare diseases. There is a vast consensus among patients, health care bodies, governments etc. to expedite drug development in this field. Some wonderful numbers that attest to growing interest in rare diseases and orphan drugs […]

Read More →

Case record form (CRF) is a wonderful and necessary tool used in clinical trials to collect data from each participating patient. CRF (also, referred as case report form) have historically been on paper (unlike electronic ones these days). Traditionally, something like carbon copy paper have been used, such that one sheet can be added to […]

Read More →

Approximately one third of people with Psoriasis report being diagnosed before age 20. The prevalence of the disease in childhood and adolescence ranges between 0.5% and 2%. According to the World Psoriasis Day consortium 125 million people worldwide have Psoriasis. Psoriasis affects about 6.7 million Americans and is estimated to affect 2–4% of the population […]

Read More →

Singapore is considered as the R&D pioneer in Asia with highly qualified clinicians, a solid and advanced infrastructure, cutting-edge technology, commitment by the government to become one of the preferred clinical research destinations worldwide. Singapore is central to the region (South East Asia) and hub of the life sciences industry, acting as a pacesetter to […]

Read More →

Pancreatitis, inflammation of pancreas, is the leading cause of GI related hospitalizations in USA and many other countries, with a medical condition requiring emergent care. The yearly incidence of Acute Pancreatitis in the United States and western countries is approximately 70-80 new cases per 100,000 population and has increased over the last decade. In 2015, […]

Read More →

What do you call a country with quality research facilities, efficient ethics and regulatory framework, diverse participant recruitment pool, research tax incentives and flexibility in conducting research? Some call it a dream destination, others Australia! It’s a country that has the world’s best researchers and health professionals, boasts a world-class research infrastructure and high standards of […]

Read More →

Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood that interfere with normal blood cells. It’s sometimes called acute myelocytic, myelogenous or granulocytic leukaemia. [1] Causes of AML The causes of AML remain largely […]

Read More →

Vietnam, known for its tourism destination, now is also a destination for clinical trials and research. With a sizeable population of 85 million, Vietnam provides a vast pool of participants, healthcare professionals and strong doctor – patient relationships, which result in a greater retention rate. [1] Clinical Trials in Vietnam Since last few years, Vietnam […]

Read More →